March 19, 2018
Study: Changes in intestines lead to reversal of diabetes after RYGB surgery
Editor's Note
Changes in gene expression in intestinal tissue of patients after Roux-en-Y gastric bypass (RYGB) surgery explain and predict blood glucose improvement and body weight loss, finds this study presented March 18 at the Endocrine Society’s annual meeting in Chicago.
The findings are based on the first 19 patients; 32 patients will be recruited for the full study.
This is the first study to link changes in intestinal biology to clinical improvement after bariatric surgery, the authors say.
Free Daily News
- HFMA warns affordability crisis is driving up provider bad debt
- Report warns sterile processing staffing crisis threatens surgical safety
- Ascension swings to profit as outpatient push, cost cuts take hold
- High BMI alone did not raise early complication risk after outpatient TJA
- AAAHC report spotlights top accreditation deficiencies, strategies for safer ambulatory care
- ACS conference charts bold future for surgical quality with data, teamwork, frontline innovation
- Surgical leaders urged to weigh risks, rewards of innovation with a critical eye
- Health systems report dramatic nurse retention gains through residency, development programs
- Surgical innovation redefines what is possible for advanced colorectal cancer
- CMS proposal to end inpatient only list draws strong industry response
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement